vimarsana.com

Page 6 - கைசர் நிரந்தர தெற்கு கலிஃபோர்னியா துறை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Physical activity may reduce risk of poor COVID-19 outcomes

 E-Mail PASADENA, Calif. A Kaiser Permanente study of nearly 50,000 people with COVID-19 suggested that regular physical activity provided strong protection from hospitalization, intensive care unit admission, and death. Even exercising inconsistently lowered the odds for severe COVID-19 outcomes when compared to people who were not active at all. The study, led by investigators in Kaiser Permanente Southern California, was published in the British Journal of Sports Medicine. This is a wake-up call for the importance of healthy lifestyles and especially physical activity, said Robert E. Sallis, MD, a family and sports medicine physician at the Kaiser Permanente Fontana Medical Center. Kaiser Permanente s motivation is to keep people healthy, and this study truly shows how important that is during this pandemic and beyond. People who regularly exercise had the best chance of beating COVID-19, while people who were inactive did much worse.

Inactivity increases risk of COVID-19 death, study suggests

Fox News medical contributor Dr. Marc Siegel argues the fear messaging following Johnson & Johnson s rare blood clotting cases is deeply problematic. A recent study of nearly 50,000 coronavirus patients found that those who were consistently inactive were at greater risk of death due to the virus than those who engaged in exercise. The study, which relied on the Exercise Vital Sign measurement developed by Kaiser Permanente Southern California, found that even those who were active on an inconsistent basis were at lower odds for severe COVID-19 compared to those who were inactive. This is a wake-up call for the importance of healthy lifestyles and especially physical activity, Robert E. Sallis, M.D., a family and sports medicine physician at the Kaiser Permanente Fontana Medical Center, said, in a news release posted to EurekAlert.org. Kaiser Permanente’s motivation is to keep people healthy, and this study truly shows how important that is during this pandemic and

Study Finds Most Patients End-of-Life Care Wishes Are Met | The Patriot KEIB AM 1150

By City News Service Apr 6, 2021 PASADENA (CNS) - The vast majority of patients make their end-of-life care wishes known to loved ones, and nearly 90% of the time those wishes were carried out, according to a Kaiser Permanente study published today in the medical journal JAMA Network Open. “There is a common perception that people don t often document or tell others about their end-of-life wishes, said the study s lead author, David Glass, a research scientist at the Kaiser Permanente Southern California Department of Research & Evaluation and lecturer in the Department of Health Systems Science at the Kaiser Permanente Bernard J. Tyson School of Medicine.

Study Finds Most Patients End-of-Life Care Wishes Are Met

By City News Service Apr 6, 2021 PASADENA (CNS) - The vast majority of patients make their end-of-life care wishes known to loved ones, and nearly 90% of the time those wishes were carried out, according to a Kaiser Permanente study published today in the medical journal JAMA Network Open. “There is a common perception that people don t often document or tell others about their end-of-life wishes, said the study s lead author, David Glass, a research scientist at the Kaiser Permanente Southern California Department of Research & Evaluation and lecturer in the Department of Health Systems Science at the Kaiser Permanente Bernard J. Tyson School of Medicine.

Pneumonia vaccine may affect course of COVID-19

Share this article Share this article PASADENA, Calif., March 10, 2021 /PRNewswire/  A Kaiser Permanente study showed that one type of pneumonia vaccine, the PCV13 vaccine, may affect the course of COVID-19 for some older adult patients. The study was published in The Journal of Infectious Diseases. Kaiser Permanente members who received the PCV13 vaccine appeared to be diagnosed with COVID-19 less often, and when they were, they seemed to have less severe outcomes, overall, said the senior author, Sara Y. Tartof, PhD, MPH, a scientist with the Kaiser Permanente Southern California Department of Research & Evaluation. One of the most interesting aspects of our findings was that the patients who received PCV13 received some protection against COVID-19, while those who received PPSV23, another pneumococcal vaccine, did not.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.